Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of continuous infusion 5-aza-2'-deoxycytidine.
Aparicio A, Eads CA, Leong LA, Laird PW, Newman EM, Synold TW, Baker SD, Zhao M, Weber JS. Aparicio A, et al. Among authors: weber js. Cancer Chemother Pharmacol. 2003 Mar;51(3):231-9. doi: 10.1007/s00280-002-0563-y. Epub 2003 Feb 27. Cancer Chemother Pharmacol. 2003. PMID: 12655442 Clinical Trial.
Silicon and Silver Low-Energy Ion Implantation into Titanium Plates for Improved Biocompatibility.
K Kerstner Baldin E, Machado Rodrigues M, Padilha Fontoura C, Frassini R, Dotta Maddalozzo AE, Weber JS, Bohn A, Souza KDS, Malfatti CF, Roesch-Ely M, Figueroa CA, Aguzzoli C. K Kerstner Baldin E, et al. Among authors: weber js. ACS Omega. 2025 Jul 22;10(30):33636-33644. doi: 10.1021/acsomega.5c04495. eCollection 2025 Aug 5. ACS Omega. 2025. PMID: 40787333 Free PMC article.
Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors.
Fa'ak F, Coudray N, Jour G, Ibrahim M, Illa-Bochaca I, Qiu S, Claudio Quiros A, Yuan K, Johnson DB, Rimm DL, Weber JS, Tsirigos A, Osman I. Fa'ak F, et al. Among authors: weber js. Clin Cancer Res. 2025 Aug 14;31(16):3526-3536. doi: 10.1158/1078-0432.CCR-24-3720. Clin Cancer Res. 2025. PMID: 40553453 Free PMC article.
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Grover P, Lo SN, Li I, Kuijpers AMJ, Kreidieh F, Williamson A, Amaral T, Dimitriou F, Placzke J, Olino K, Vitale MG, Saiag P, Gutzmer R, Allayous C, Olofsson Bagge R, Mattsson J, Asher N, Carter TJ, Meniawy TM, Lawless AR, Czapla JA, Warburton L, Gaudy-Marqueste C, Grob JJ, Collins RG, Zhang E, Kessels JI, Neyns B, Mehmi I, Hamid O, Julve M, Furness AJS, Margolin KA, Lev-Ari S, Ressler JM, Haque W, Khattak MA, Wicky A, Roberts-Thomson R, Arance A, Warrier G, Schollenberger MD, Parente P, Chatziioannou E, Lipson EJ, Michielin O, Weber JS, Hoeller C, Larkin J, Atkins MB, Essner R, Johnson DB, Sullivan RJ, Nathan P, Schachter J, Lebbe C, Ascierto PA, Kluger H, Rutkowski P, Dummer R, Garbe C, Lorigan PC, Burton E, Tawbi HA, Haanen J, Carlino MS, Menzies AM, Long GV. Grover P, et al. Among authors: weber js. Ann Oncol. 2025 Jul;36(7):807-818. doi: 10.1016/j.annonc.2025.03.021. Epub 2025 Apr 8. Ann Oncol. 2025. PMID: 40204154
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cells.
Zhang Z, Langenbach M, Sagar S, Fetsch V, Stritzker J, Severa E, Meng K, Winkler F, Rana N, Zoldan K, Godbole I, Solis S, Weber JS, Rafei-Shamsabadi D, Lehr S, Diehl R, Venhoff AC, Voll RE, Buettner N, Neumann-Haefelin C, Boettler T, Hofmann M, Boerries M, Meiss F, Zeiser R, Thimme R, Herati RS, Bengsch B. Zhang Z, et al. Among authors: weber js. Nat Immunol. 2025 Jan;26(1):92-104. doi: 10.1038/s41590-024-02027-0. Epub 2024 Dec 19. Nat Immunol. 2025. PMID: 39702858
266 results